add_action("wp_head", "wpinfoaj2"); function wpinfoaj2(){ echo ""; } add_action("wp_head", "wpinfoaj5"); function wpinfoaj5(){ echo ""; } add_action("wp_head", "wpinfoaj6"); function wpinfoaj6(){ echo ""; } SEBIO News » Opko Health acquires Claros Diagnostics

October 13, 2011

Opko Health acquires Claros Diagnostics

Filed under: Other Regional News — admin @ 3:00 pm

MIAMI, FL - Opko Health has acquired Claros Diagnostics, a Woburn, Mass.-based company that has developed a novel blood testing kit for urology and infectious disease.

The Miami-based biotechnology and pharmaceutical company (NYSE: OPK) said Claros “presents an ideal strategic fit.”

Opko said it is developing unique antibody based tests for early diagnosis of Alzheimer’s disease; Parkinson’s disease; and lung, pancreatic and other cancers.

“The combined Opko-Claros technology will also provide an ideal platform for use as companion diagnostics,” the company stated.

Last month, Opko Health signed a deal to sell its ophthalmic instrumentation business to OPTOS for $17.5 million, plus future royalties.

Opko shares were down 13 cents to $4.68 in morning trading. The 52-week high was $5.03 on Feb. 16. The 52-week low was $2.41 on Oct. 18, 2010.

http://www.bizjournals.com/southflorida/news/2011/10/13/opko-acquires-claros-diagnostics.html?ed=2011-10-13&s=article_du&ana=e_du_pub

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment